Are QALYs based on time trade-off comparable? - A systematic review of TTO methodologies

Health Economics

Volumn 14, Issue 1, 2005, Pages 39-53

  Arnesen, Trude ^a,b   Trommald, Mari ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Fafo   (Norway)

Author keywords

Cost utility analysis; QALY; Quality of life weight; Respondent's own health; Standardisation of methods; Time trade off

Indexed keywords

AGE DISTRIBUTION; COMORBIDITY; COST UTILITY ANALYSIS; EMPLOYMENT; GENDER; HEALTH STATUS; HUMAN; HYPOTHESIS; INTERMETHOD COMPARISON; MEDICAL LITERATURE; METHODOLOGY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGENY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; TIME; VALIDATION PROCESS;

ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; DIAGNOSIS-RELATED GROUPS; EMPIRICAL RESEARCH; HEALTH PRIORITIES; HUMANS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 12344257034     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.895     Document Type: Review

References (42)

1. Nord E. Methods for quality adjustment of life years. Soc Sci Med 1992; 34(5): 559-569.
2. Tsevat J, Dawson NV, Wu AW et al. Health values of hospitalized patients 80 years or older. HELP Investigators. JAMA 1998; 279(5): 371-375.
3. Clarke AE, Goldstein MK, Michelson D, Garber AM, Lenert LA. The effect of assessment method and respondent population on utilities elicited for Gaucher disease. Qual Life Res 1997; 6(2): 169-184.
4. Jansen SJT, Stiggelbout AM, Wakker PP, Nooij MA, Noordijk EM, Kievit J. A shift in valuation or an effect of the elicitation procedure? Med Decis Making 2000; 20: 62-71.
5. Molzahn AE, Northcott HC, Dossetor JB. Quality-of-life of individuals with end stage renal disease: perceptions of patients, nurses, and physicians. Anna J 1997; 24(3): 325-333.
6. Neumann PJ, Zinner DE, Wright JC. Are methods for estimating QALYs in cost-effectiveness analyses improving? Med Decis Making 1997; 17(4): 402-408.
7. Dolan P, Gudex C, Kind P, Williams A. Valuing health states: a comparison of methods. J Health Econ 1996; 15(2): 209-231.
8. Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol 1992; 45(5): 505-512.
9. Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes. Comparison of assessment methods. Med Decis Making 1984; 4(3): 315-329.
10. Robinson A, Dolan P, Williams A. Valuing health status using VAS and TTO: what lies behind the numbers? Soc Sci Med 1997; 45 8): 1289-1297.
11. Ubel PA, Loewenstein G, Scanlon D, Kamlet M. Individual utilities are inconsistent with rationing choices: a partial explanation of why Oregon's cost-effectiveness list failed. Med Decis Making 1996; 16(2): 108-116.
12. Bell CM, Chapman RH, Stone PW, Sandberg EA, Neumann PJ. An off-the shelf help list. A comprehensive catalog of preference scores from published cost-utility analyses. Med Decis Making 2001; 21 288-294.
13. Arnesen TM, Trommald M. Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method. J Health Serv Res Pol 2004; 9(1): 43-50.
14. Perez DJ, McGee R, Campbell AV, Christensen EA, Williams S. A comparison of time trade-off and quality-of-life measures in patients with advanced cancer. Qual Life Res 1997; 6(2): 133-138.
15. Quenec'hdu S, Hebert R. The value of autonomy in daily living activities for elderly people who have lost their autonomy. [French]. Can J Aging 1995; 14(4): 706-718.
16. Wells KB, Sherbourne CD. Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices. Arch Gen Psychiat 1999; 56 10): 897-904.
17. Laupacis A, Bourne R, Rorabeck C et al. The effect of elective total hip replacement on health-related quality-of-life. J Bone and Joint Surg - Am 1993; 75(11): 1619-1626.
18. Lenert LA, Hornberger JC, Cher DJ et al. The effect of search procedures on utility elicitations. Med Decis Making 1998; 18(1): 76-83.
19. Hamel MB, Phillips RS, Davis RB et al. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. Ann Internal Med 1997; 127 3): 195-202.
20. Cinahl database. http://www.cinahl.com/about/about.htm [10 February 2003].
21. McLeod RS, Churchill DN, Lock AM, Vanderburgh S, Cohen Z. Quality-of-life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991; 101(5): 1307-1313.
22. Lundberg L, Johannesson M, Isacson DGL, Borgquist L. Health-state utilities in a general population in relation to age, gender and socio-economic factors. Eur J Publ Health 1999; 9(3): 211-217.
23. Fryback DG, Dasbach EJ, Klein R. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993; 13: 89-102.
24. Buckingham JK, Birdsall J, Douglas JG. Comparing three versions of the time tradeoff: time for a change? Med Decis Making 1996; 16(4): 335-347.
25. Stiggelbout AM, Kiebert GM, Kievit J, Leer JW, Habbema JD, de Haes JC. The 'utility' of the Time Trade-Off method in cancer patients: feasibility and proportional Trade-Off. J Clin Epidemiol 1995; 48(10): 1207-1214.
26. Stalmeier PF, Goldstein MK, Holmes AM et al. What should be reported in a methods section on utility assessment? Med Decis Making 2001; 21: 200-207.
27. Fowler FJ, Cleary PD, Massagli MP, Weissman J, Epstein A. The role of reluctance to give up life in the measurement of the values of health states. Med Decis Making 1995; 15: 195-200.
28. Arnesen T, Norheim OF. Quantifying quality-of-life for economic analysis: time-out for Time trade-off. J Med Eth Med Hum 2003; 29: 81-86.
29. Dolan P, Sutton M. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Soc Sci Med 1997; 44(10): 1519-1530.
30. Murray C, Lopez A. The Global Burden of Disease. Harvard University Press: Cambridge, MA, 1996.
31. Anand S, Hanson K. Disability-adjusted life years: a critical review. J Health Econ 1997; 16: 685-702.
32. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. Br Med J 1999; 319: 1423-1425.
33. Arnesen T, Kapiriri L. Can the value choices in DALYs influence global priority setting? Health Policy 2003, DOI: 10.1016/j.healthpol.2003.08.004.
34. Mansley EC, Elbasha EH. Preferences and person trade-offs: forcing consistency or inconsistency in health-related quality-of-life measures? Health Econ 2003; 12: 187-198.
35. Green C. On the societal value of health care: what do we know about the person trade-off technique? Health Econ 2001; 10 3): 233-243.
36. Salomon JA, Murray CJL. Estimating health state valuations using a multiple-method protocol. In Summary Measures of Population Health, Murray CJL, Salomon JA, Mathers C, Lopez AD (eds). World Health Organisation: Geneva; 2003: 487-498.
37. Bleichrodt H, Johannesson M. The validity of QALYs; an experimental test of constant proportional tradeoff and utility independence. Med Decis Making 1996; 17: 21-32.
38. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ 1996; 5(2): 141-154.
39. Stiggelbout AM, de Haes JC, Kiebert GM, Kievit J, Leer JW. Tradeoffs between quality and quantity of life: development of the QQ Questionnaire for Cancer Patient Attitudes. Med Decis Making 1996; 16(2): 184-192.
40. Mohide EA, Torrance GW, Streiner DL, Pringle DM, Gilbert R. Measuring the well-being of family caregivers using the time trade off technique. J Clin Epidemiol 1988; 41(5): 475-482.
41. Zethraeus N, Johannesson M, Henriksson P, Strand RT. The impact of hormone replacement therapy on quality-of-life and willingness to pay. Br J Obstet Gynaecol 1997; 104(10): 1191-1195.
42. Tsevat J. What do utilities measure? Med Care 2000; 38(9): 160-164.